Kathryn B. McKenzie - 11 Jan 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: Chief Sustainability/Risk Ofcr
Issuer ticker: NEO
Reported as of: 11 Jan 2022
Net transaction value: +$19,047
SEC form: 4
Accepted by SEC: 12 Jan 2022, 17:50:42 UTC
Prior SEC filing: 30 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Kathryn B McKenzie

Key filing fact

Kathryn B. McKenzie filed Form 4 for NEOGENOMICS INC (NEO) on 12 Jan 2022.

Key facts

This page summarizes Kathryn B. McKenzie's Form 4 filing for NEOGENOMICS INC (NEO).
2 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 12 Jan 2022, 17:50.

Change

Previous filing in this sequence was filed on 30 Dec 2021.
Current net transaction value: +$19,047.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value: $19,047
Shares: +2,100
Change %: +4.4%
Price: $9.07
Shares after: 49,361
Date: 11 Jan 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,100
Change %: -10%
Price: $0.000000
Shares after: 17,900
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,100
Exercise price: $9.07
Footnotes: F1

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 40,000
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $8.03
Footnotes: F2

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,894
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,894
Exercise price: $19.60
Footnotes: F3

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,514
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,514
Exercise price: $28.33
Footnotes: F4

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,171
Date: 11 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,171
Exercise price: $53.17
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

Footnote F2

On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

Footnote F3

On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F4

On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F5

On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.